Over- the- counter weight- loss pills: Do they work? Over- the- counter weight- loss pills. The temptation to use over- the- counter weight- loss pills to lose weight fast is strong. But are these products safe and effective? Feel healthy, stay in shape. ELLO CORPORATION'S nutritional products have been manufactured to meet the highest current standards while using the best ingredients. ![]() Dietitian's Review of popular slimming tablets from Adios to Zotrim. Is Sletrokor Diet Pills a scam? Sletrokor review, ingredients, side effects, dosage, coupons. 27 real customer reviews. Buy one get one half price on selected items as well as even more Big Deals at better than half price when you shop at Holland & Barrett today! ECA Xtreme Ephedra by Hi-Tech is a highly effective diet pill to promote weight-loss & supress your appetite. Buy ECA Extreme Ephedra for $29.99 & read reviews online. ![]() ![]() By Mayo Clinic Staff. The appeal of losing weight quickly is hard to resist. But do weight- loss pills and products lighten anything but your wallet? And are they a safe option for weight loss? Here's a look at some over- the- counter weight- loss pills and what they will and won't do for you. Setting realistic expectations. There's no magic bullet for losing weight. The most effective way to lose weight and keep it off is through lifestyle changes. Eat a healthy low- calorie diet with lots of fruits and vegetables and be physically active. Weight- loss pills — prescription medicines, nonprescription drugs, herbal medicines or other dietary supplements — are all, at best, tools that may help with weight loss. But there is relatively little research about these products, and the best studied of these are prescription weight- loss drugs. For example, a 2. The researchers concluded that when a person makes appropriate lifestyle changes, a prescription weight- loss drug increases the likelihood of achieving . Also, possible side effects and adverse reactions to weight- loss pills can affect the treatment outcome. A reasonable expectation, therefore, is that prescription weight- loss pills may be beneficial, but they won't be magical. They do not work for everyone, and their benefit may be modest. And researchers know much less about the potential benefits and risks of over- the- counter weight- loss products. Understanding over- the- counter treatment regulations. Over- the- counter weight- loss treatments fall into two general categories: Nonprescription drugs. Dietary supplements. The standards for regulating the production and marketing of these two types of treatments are different. For a nonprescription drug, such as orlistat (Alli), the drug company must provide the Food and Drug Administration (FDA) with results from human (clinical) trials that show the safety and effectiveness of the drug at the nonprescription dose. The maker of a dietary supplement is responsible for ensuring the safety of a product and making honest claims about possible benefits. However, the maker's claims are not subject to FDA review or approval before marketing. Also, the type or quality of research used to support claims can vary. If the FDA can demonstrate that a substance is unsafe, the agency can ban the product or ask a manufacturer to withdraw it voluntarily. The FDA may also take action against a manufacturer if there is no evidence at all to support a claim. These differences in research, production and marketing can make it difficult for people to make informed decisions about products. Interpreting claims on weight- loss supplements. When a dietary supplement is marketed as . Such a claim, however, provides no details about the clinical research. For example, raspberry ketone supplements are marketed as clinically proven, natural weight- loss products. As of November 2. The results include the following information: The eight- week trial used a multi- ingredient supplement with raspberry ketone, caffeine, bitter orange, ginger root extract and garlic root extract, as well as other herbs, vitamins and minerals. Seventy obese adults were randomly assigned to receive either the supplement or an inactive ingredient (placebo). All of the participants were placed on a restricted diet and exercise program. Forty- five people completed all eight weeks of the trial. Among people completing the trial, the average weight loss in the supplement group was 4. The average weight loss in the placebo group was 0. While the difference between the two groups was significant, the weight loss in the treatment group was still modest. And the trial was only eight weeks, which is not long enough to know if the supplement will help promote weight loss over the long term. Because the supplement included multiple ingredients, it's not possible to judge which ingredients caused a treatment effect. Therefore, the size, method and duration of the trial provide insufficient evidence to draw conclusions about the potential benefits of raspberry ketone. Dec. 1. 9, 2. 01. Dietary supplements for weight loss. National Institutes of Health Office of Dietary Supplements. Accessed Nov. 1. 3, 2. Hensrud DD (expert opinion). Mayo Clinic, Rochester, Minn. Yanovski SZ, et al. Long- term drug treatment for obesity: A systematic and clinical review. Lopez HL, et al. Eight weeks of supplementation with a multi- ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women. Journal of the International Society of Sports Nutrition. Bitter orange. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Alli. Glaxo. Smith. Kline Consumer Healthcare, L. P. Accessed Nov. 2. Bitter orange. National Center for Complementary and Alternative Medicine. Accessed Nov. 2. 6, 2. Chitosan. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Chromium. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Conjugated linoleic acid. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Onakpoya I, et al. The use of green coffee extract as a weight loss supplement: A systematic review and meta- analysis of randomised clinical trials. Gastroenterology Research and Practice. Green coffee extract. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Green tea extract. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Guar gum. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. Hoodia. Natural Medicines Comprehensive Database. Accessed Nov. 2. 3, 2. See more In- depth. CHITOSAN: Uses, Side Effects, Interactions and Warnings. References: Aspden, T. J., Mason, J. D., Jones, N. S., Lowe, J., Skaugrud, O., and Illum, L. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 1. 99. View abstract. Brandenberg, G., Leibrock, L. G., Shuman, R., Malette, W. G., and Quigley, H. Chitosan: a new topical hemostatic agent for diffuse capillary bleeding in brain tissue. Neurosurgery 1. 98. View abstract. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials 1. 99. View abstract. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials 1. 99. View abstract. Deuchi K, Kanauchi O, Imasato Y, and et al. Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high- fat diet. Biosci Biotech Biochem 1. Deuchi, K., Kanauchi, O., Imasato, Y., and Kobayashi, E. Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high- fat diet. Biosci Biotechnol. Biochem 1. 99. 5; 5. View abstract. Deuchi, K., Kanauchi, O., Shizukuishi, M., and Kobayashi, E. Continuous and massive intake of chitosan affects mineral and fat- soluble vitamin status in rats fed on a high- fat diet. Biosci Biotechnol. Biochem 1. 99. 5; 5. View abstract. Ernst E and Pitter MH. Chitosan as a treatment for body weight reduction? A meta- analysis. Perfusion 1. 99. 8; 1. Girola M, De Bernardi M, and Contos S, et al. Dose effect in lipid- lowering activity of a new dietary integrator (chitosan, Garcinia cambogia extract, and chrome). Acta Toxicol Ther 1. M., Miyazaki, S., Takada, M., and Komai, T. Sustained release of indomethacin from chitosan granules. Chem Pharm Bull (Tokyo) 1. View abstract. Illum, L., Jabbal- Gill, I., Hinchcliffe, M., Fisher, A. N., and Davis, S. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv. Rev 9- 2. View abstract. Kanauchi O, Deuchi K, Imasato Y, and et al. Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion. Biosci Biotech Biochem 1. Kanauchi, O., Deuchi, K., Imasato, Y., Shizukuishi, M., and Kobayashi, E. Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. Biosci. Biotechnol. Biochem 1. 99. 5; 5. View abstract. M., Bines, S. D., Staren, E. D., Templeton, A. J., and Economou, S. Chitosan: evaluation of a new hemostatic agent. View abstract. Chitin- chitosan: properties, benefits and risks. Nutrition Research 1. Kondo, Y., Nakatani, A., Hayashi, K., and Ito, M. Low molecular weight chitosan prevents the progression of low dose streptozotocin- induced slowly progressive diabetes mellitus in mice. Biol Pharm Bull 2. View abstract. Kratz, G., Back, M., Arnander, C., and Larm, O. Immobilised heparin accelerates the healing of human wounds in vivo. Scand J Plast. Reconstr. Surg Hand Surg 1. View abstract. Some effects of chitosan on liver function in the rat. Endocrinology 1. 99. View abstract. A new approach to the treatment of obesity: chitosan's effects on body weight reduction and plasma cholesterol levels. Acta Toxicol Ther 1. Maezaki Y, Tsuji K, Nakawa, and et al. Hypocholesterolaemic effect of chitosan in adult males. Biosc Biochem Biotech 1. G., Quigley, H. J., Gaines, R. D., Johnson, N. D., and Rainer, W. Chitosan: a new hemostatic. Ann Thorac. Surg. View abstract. Miura, T., Usami, M., Tsuura, Y., Ishida, H., and Seino, Y. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin- induced diabetic mice. Biol Pharm Bull 1. View abstract. L., Alexander, J. W., Gianotti, L., Chalk, C. L., and Pyles, T. Influence of dietary fiber on microbial growth in vitro and bacterial translocation after burn injury in mice. Nutrition 1. 99. 4; 1. View abstract. Petronio, M. G., Mansi, A., Gallinelli, C., Pisani, S., Seganti, L., and Chiarini, F. In vitro effect of natural and semi- synthetic carbohydrate polymers on Chlamydia trachomatis infection. Chemotherapy 1. 99. View abstract. Polyacrylamide- chitosan hydrogels: in vitro biocompatibility and sustained antibiotic release studies. View abstract. Ruel- Gariepy, E., Chenite, A., Chaput, C., Guirguis, S., and Leroux, J. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 8- 1. View abstract. Sano H, Shibasaki K Kaneko K and et al. Inhibitory effect of chitosan rinsing on plaque formation. J- Dent- Res 1. 99. March Special Issue A: Abstracts of papers): 1. Abs No 2. 60). Sano, H., Shibasaki, K., Matsukubo, T., and Takaesu, Y. Effect of chitosan rinsing on reduction of dental plaque formation. Bull. Tokyo Dent. Coll. 2. 00. 3; 4. View abstract. Sawayanagi, Y., Nambu, N., and Nagai, T. Use of chitosan for sustained- release preparations of water- soluble drugs. Chem Pharm Bull (Tokyo) 1. View abstract. Schiller RN, Barrager E, Schauss EA, and et al. A randomized, double- blind, placebo- controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. J Am Nutraceutical Assoc 2. Sciutto AM and Colombo P. Lipid- lowering effect of chitosan dietary integrator and hypocaloric diet in obese patients. Acta Toxicol Ther 1. Senel, S., Kremer, M. J., Kas, S., Wertz, P. W., Hincal, A. A., and Squier, C. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2. 00. View abstract. Shibasaki, K., Sano, H., Matsukubo, T., and Takaesu, Y. Bull Tokyo Dent Coll 1. View abstract. A., Wright, H., Clarke, T., Powell, R., and Devaraj, V. Healing at skin graft donor sites dressed with chitosan. Br J Plast. Surg. View abstract. S., Sheu, W. T., and Chiang, M. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia. Diabetes Care 2. 00. View abstract. Tanaka, Y., Tanioka, S., Tanaka, M., Tanigawa, T., Kitamura, Y., Minami, S., Okamoto, Y., Miyashita, M., and Nanno, M. Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration. Biomaterials 1. 99. View abstract. Tarsi, R., Muzzarelli, R. A., Guzman, C. A., and Pruzzo, C. Inhibition of Streptococcus mutans adsorption to hydroxyapatite by low- molecular- weight chitosans. J Dent Res 1. 99. View abstract. Antibacterial activity of shrimp chitosan against Escherichia coli. J Food Prot. 1. 99. View abstract. F., Schatzlein, A. G., Tetley, L., Gray, A. I., Sludden, J., Siddique, S., and Mosha, E. Polymeric chitosan- based vesicles for drug delivery. J Pharm Pharmacol 1. View abstract. Valenta, C., Christen, B., and Bernkop- Schnurch, A. Chitosan- EDTA conjugate: a novel polymer for topical gels. J Pharm Pharmacol 1. View abstract. Veneroni G, Veneroni F, Contos S, and et al. Effect of new chitosan dietary integrator and hypocaloric diet on hyperlipidemia and overweight in obese patients. Acta Toxicol Ther 1. Wuolijoki, E., Hirvela, T., and Ylitalo, P. Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find. Exp Clin Pharmacol. View abstract. Yamada, T., Onishi, H., and Machida, Y. In vitro and in vivo evaluation of sustained release chitosan- coated ketoprofen microparticles. Yakugaku Zasshi 2. View abstract. Biagini G, Bertani A, Muzzarelli R, et al. Wound management with N- carboxybutyl chitosan. Biomaterials 1. 99. View abstract. Bokura H, Kobayashi S. View abstract. Colombo P, Sciutto AM. Acta Toxicol Therap 1. Gades MD, Stern JS. J Am Diet Assoc 2. View abstract. Gades MD, Stern JS. Int J Obes 2. 00. View abstract. Gallaher DD, Gallaher CM, Mahrt GJ, et al. View abstract. Giustina A, Ventura P. Acta Toxicol Ther 1. Guerciolini R, Radu- Radulescu L, Boldrin M, et al. Obes Res 2. 00. 1; 9: 3. View abstract. Hayashi Y, Ohara N, Ganno T, et al. Chewing chitosan- containing gum effectively inhibits the growth of cariogenic bacteria. Arch Oral Biol 2. View abstract. Ho SC, Tai ES, Eng PH, et al. Singapore Med J 2. View abstract. Huang SS, Sung SH, Chiang CE. Chitosan potentiation of warfarin effect. Ann Pharmacother 2. View abstract. Jing SB, Li L, Ji D, et al. J Pharm Pharmacol 1. View abstract. Macchi G. Acta Toxicol Ther 1. Metso S, Ylitalo R, Nikkila M, Wuolijoki E, et al. View abstract. Mhurchu CN, Poppitt SD, Mc. Gill AT, et al. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 2. Int J Obes Relat Metab Disord 2. View abstract. Muzzarelli R, Biagini G, Pugnaloni A, et al. Reconstruction of parodontal tissue with chitosan. Biomaterials 1. 98. View abstract. Muzzarelli R, Tarsi R, Fillippini O, et al. Antimicrobial properties of N- carboxybutyl chitosan. Antimicrob Agents Chemother 1. View abstract. Muzzarelli RA, Biagini G, Bellardini, et al. Osteoconduction exerted by methylpyrrolidinone chitosan used in dental surgery. Biomaterials 1. 99. View abstract. Ni Mhurchu C, Dunshea- Mooij C, Bennett D, Rodgers A. Chitosan for overweight or obesity. Cochrane Database Syst Rev 2. CD0. 03. 89. 2. View abstract. Pittler MH, Abbot NC, Harkness EF, Ernst E. Randomized, double- blind trial of chitosan for body weight reduction. Eur J Clin Nutr 1. View abstract. Rao SB, Sharma CP. View abstract. Sciutto AM, Colombo P. Acta Toxicol Ther 1. Shields KM, Smock N, Mc. Queen CE, Bryant PJ. View abstract. Thanou M, Verhoef JC, Junginger HE. View abstract. Tsujikawa T, Kanauchi O, Andoh A, et al. A pilot study. Nutrition 2. View abstract. Ueno H, Mori T, Fujinaga T. Adv Drug Deliv Rev 2. View abstract. Veneroni G, Veneroni F, Contos S, et al. Acta Toxicol Ther 1. Wuolijoki E, Hirvela T, Ylitalo P. Decrease in serum LDL cholesterol with microcrystalline chitosan. Methods Find Exp Clin Pharmacol 1. Ylitalo R, Lehtinen S, Wuolijoki E, et al. View abstract. Aiedeh, K., Gianasi, E., Orienti, I., and Zecchi, V. Chitosan microcapsules as controlled release systems for insulin. J Microencapsul. 1.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2017
Categories |